55 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
10 May 22
Aurinia Reports First Quarter 2022 Financial and Operational Results
6:06am
on assumptions regarding the impact of COVID-19 on the current business environment and represents an increase of more than 150 to 200% in net revenue from sales
8-K
EX-99.1
21l2bv p55
28 Feb 22
Aurinia Reports Fourth Quarter and Full Year 2021 Financial Results and Company Updates
6:08am
S-3ASR
EX-1.2
wwo3u1jquwi321kpma7b
19 Nov 21
Automatic shelf registration
5:04pm
S-3ASR
6szr2nj6x2sc0ku
19 Nov 21
Automatic shelf registration
5:04pm
DEF 14A
f6vhdgqzftp jbd6
10 May 21
Definitive proxy
4:06pm
PRE 14A
ozetezl whzyru0g0c
27 Apr 21
Preliminary proxy
4:32pm
10-K
152u5omkakw 3t6zdjn2
24 Feb 21
Annual report
4:09pm
10-K
EX-10.6
7eb42otpkkim9dd
24 Feb 21
Annual report
4:09pm
10-K
EX-10.7
j2gciyr9hnb2s1cuyzq
24 Feb 21
Annual report
4:09pm
10-K
EX-10.8
nui tgpqq
24 Feb 21
Annual report
4:09pm
10-K
EX-10.17
eugnhe3xd6
24 Feb 21
Annual report
4:09pm
6-K
EX-99.2
n7rof2kmdra x6
30 Dec 20
Material Change Report
5:30pm
6-K
EX-99.1
ko569gkl879z1fw8e
16 Dec 20
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.2
lggmo
10 Nov 20
Current report (foreign)
4:05pm
6-K
EX-99.2
16kcktadc06qzpivvz30
11 Aug 20
Current report (foreign)
4:04pm